Melinta Therapeutics Demonstrates Potential of Pyrrolocytosine Candidate against Gonorrhea New Haven, Conn., June 05, 2017 (GLOBE NEWSWIRE) -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat serious bacterial infections, announced that an oral...

Melinta Therapeutics Presenting In Vivo and In Vitro Results from Baxdela Studies at ASM Microbe New Haven, Conn, June 01, 2017 (GLOBE NEWSWIRE) -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat serious bacterial infections, announced today that five...